SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-024900
Filing Date
2022-09-14
Accepted
2022-09-14 16:05:25
Documents
13
Period of Report
2022-09-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ocgn-20220914.htm   iXBRL 8-K 35980
2 EX-99.1 ocgn-20220914xex991.htm EX-99.1 11312
  Complete submission text file 0001628280-22-024900.txt   185422

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ocgn-20220914.xsd EX-101.SCH 1896
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ocgn-20220914_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ocgn-20220914_pre.xml EX-101.PRE 12504
7 EXTRACTED XBRL INSTANCE DOCUMENT ocgn-20220914_htm.xml XML 10641
Mailing Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36751 | Film No.: 221243056
SIC: 2836 Biological Products, (No Diagnostic Substances)